Teva's Plan B One-Step OTC Application Puts FDA On The Spot
This article was originally published in The Tan Sheet
Executive Summary
Teva Pharmaceutical Industries asks FDA to allow over-the-counter sales of Plan B One-Step, starting the likely final leg of the emergency contraceptive's journey toward OTC status.
You may also be interested in...
Study Suggests Emergency Contraception Potential For Regular Use
Authors of a literature review suggest that 0.75 mg doses of levonorgestrel, currently used as an emergency contraceptive, may be safe and effective as a primary means of birth control in some populations but note that "rigorous new" safety and efficacy data would be needed to support such use.
Benefits, Pitfalls Of OTC Birth Control Apparent In Cross-Border Study
A pair of reports from a study of women who accessed birth control pills over the counter or by prescription showcases the benefits and challenges inherent in nonprescription oral contraceptives.
In Brief
EC drug goes nonprescription in Ireland